Anti-A33 [huA33] |
Human |
deplete, ELISA, IF, IHC |
Anti-Alpha-fetoprotein (AFP) [AF5] |
Human |
WB, FC, IF |
Anti-Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 [32C8_71] |
Human |
DSF, SPR, ELISA |
Anti-BCL2 [bcl-2/100] |
Human |
IP, WB, IHC |
Anti-Beta-2 microglobulin [BBM.1] |
Human |
Depletion, WB, IF, IHC |
Anti-BLC2 [bcl-2/124] |
Human |
IP, WB, IHC |
Anti-Breast Epithelial Mucin [BrE-3] |
Human |
ELISA |
Anti-c-erbB-2 [FWP51] |
Human |
fusion, IP, FC, IF |
Anti-CA125 [196-14] |
Human |
ELISA, IHC |
Anti-CA125 [OC125-3.11] |
Human |
IP, WB, ELISA, FC, IF, IHC |
Anti-CA125 [VK-8-1.9] |
Human |
IP, WB, ELISA, FC, IF, IHC |
Anti-Canine Lymphoma [Mab231] |
Dog, Human |
RIA, FC |
Anti-carcinoembryonic antigen (CEA) [Arcitumomab] |
Human |
IHC-P, FC, Imaging |
Anti-carcinoembryonic antigen [A5B7] |
Human |
radiolabelling, therapeutic, IHC |
Anti-CD19 [B4] |
Human |
FC, IF, IHC |
Anti-CEA [BW431/26] |
Human |
Immunoscintigraphy |
Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)] |
Human |
ELISA, FC, IHC |
Anti-CEA [EB-011] |
Human |
ELISA |
Anti-CEA [EB-022] |
Human |
ELISA |
Anti-CEA [T84.66] |
Human |
Immunoscintigraphy, immunotherapy, RIA, ELISA, FC, IHC |
Anti-CSAp [Mu-9] |
Human |
therapeutic, ELISA, IHC |
Anti-Ctip2 [25B6] |
Guinea Pig, Rat, Zebrafish, Human, Cynomolgus Monkey, Mouse |
CHIP, IHC-P, IP, WB, FC, IF, IHC-Fr |
Anti-Cytokeratin 7 [OV-TL 12/30] |
Human |
WB, FC, IF, IHC |
Anti-Cytokeratin 8 [TS1] |
Human |
IP, radioimmunotherapy, WB, ELISA, IHC |
Anti-deltaEGFR [DH8.3] |
Human |
IP, WB, ELISA, FC, IHC |
Anti-EGFR [2F8 (Zalutumumab; HuMax-EGFR)] |
Human |
WB, ELISA, FC |
Anti-EGFR [2224] |
Human |
FC |
Anti-EGFR [528] |
Human |
IHC-P, IP, NTRL, WB, FC, IF |
Anti-EGFR [C225 (Cetuximab)] |
Human |
Block, FC |
Anti-EGFR [EGFR1] |
Human |
IP, WB, FC, IF, IHC |
Anti-EGFR [L2 1C] |
Human |
WB, ELISA, FC |
Anti-EGFR [L3 11D] |
Human |
SDS-PAGE, WB, ELISA, FC |
Anti-EGFR [Matuzumab] |
Human |
antagonist, WB, Block, ELISA, FC, IF |
Anti-EGFR [S3 12D] |
Human |
ICC, WB, ELISA, IF, IHC |
Anti-EGFR [S4 10H] |
Human |
WB, ELISA, FC |
Anti-EGFR domain III [h-R3 (Nimotuzumab)] |
Human |
Block, FC, IHC |
Anti-EGFRvIII [L8A4] |
Human |
Biacore, WB, ELISA, FC, IF, IHC |
Anti-Endosialin [scFv78] |
Human, Mouse |
tumor imaging, ELISA, FC |
Anti-EPCAM [B38.1] |
Human |
RIA, ELISA |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
Human |
ELISA, FC, IHC |
Anti-ERBB2 [SAIC-02A-7] |
Human |
immunoMRM, WB, ELISA |
Anti-GA733-2 [FU-MK-1] |
n/a |
IB, ICC, WB, ELISA, IHC |
Anti-HER2 [4D5] |
Human |
crystallization, in vivo, inibition, IP, therapeutic, FC |
Anti-HER2 [C7b] |
Human |
cytometric bead array, WB, ELISA, FC, IHC |
Anti-HER2 [ML3-9 (C6ML3-9)] |
Human |
RIA, SPR, FC |
Anti-HER2/neu [SER4] |
Human |
ELISA |
Anti-HER3 [A5 ] |
Human |
SPR, FC |
Anti-HER4 [B6 (HER4.B6)] |
Human |
ELISA |
Anti-high MWT epithelial antigens [KC4G3] |
Human |
WB, IHC |
Anti-Human Ephrin Type A receptor 2 [1C1] |
Human |
agonist, internalizing, WB, ELISA, FC, IF |
Anti-Ki-67 [685P3B2 ] |
Human |
WB, ELISA, IHC |
Anti-Ki-67 [73043-24E8] |
Human |
WB, ELISA, IHC |
Anti-Lewis Y [3S193] |
Human |
humanisation, ELISA, IHC |
Anti-LeY [BR96] |
Human |
ELISA, IHC |
Anti-LeY [H18A] |
Human |
ELISA, IHC |
Anti-LMP1 [H3] |
Epstein-Barr virus (EBV) |
inhibit, IP, ELISA, IF |
Anti-m5C [FMC-9] |
Species independent |
ICC, IPP, WB, ELISA, IHC |
Anti-MAGE-3 [21B4] |
Human |
IP, WB, ELISA, IHC |
Anti-Mesothelin [11-25] |
Human |
IP, ELISA, FC |
Anti-Mesothelin [C10] |
Human |
SPR, ELISA, IHC |
Anti-Mesothelin [IC14-30] |
Human |
ELISA |
Anti-Mesothelin [K1] |
Cynomologous monkey, Human |
RIA, SPR, WB, ELISA, IF, IHC |
Anti-MPF [20-10] |
Human |
IP, WB, ELISA |
Anti-MPF [41-28] |
Human |
IP, WB, ELISA |
Anti-MUC-1 [E29] |
Human |
WB, IHC |
Anti-MUC1 [HMFG1 (1.10.F3)] |
Human |
IP, RIA, WB, ELISA, IF, IHC |
Anti-MUC1 [HMFG2] |
Human |
ELISA, IHC, Imaging |
Anti-MUC1 [Mc5] |
Human |
IP, IRA, WB, ELISA, IHC |
Anti-MUC1 [PAM4] |
Human |
therapeutic, WB, ELISA, FC, IHC |
Anti-MUC1 [SM3] |
Human |
ELISA; IHC-P, FC, IHC-Fr |
Anti-NSE [E1-7E2] |
Human |
WB, ELISA |
Anti-NSE [E2-4F6] |
Human |
WB, ELISA |
Anti-OA3 [OV-TL3] |
Human |
IB, WB, Block, ELISA, IF, IHC |
Anti-osteosarcoma-associated cell membrane antigen [TP-1] |
Dog, Human |
radioimmunodetection, IF, IHC |
Anti-osteosarcoma-associated cell membrane antigen [TP-3] |
Dog, Human |
radioimmunodetection, IF, IHC |
Anti-p21 [Y13-238] |
Human, Mouse |
IP; |
Anti-p53 [PAb421] |
Monkey, Rabbit, Rat, Human, Mouse |
IHC -P, in vivo, IP, WB, ELISA, IF, IHC-Fr |
Anti-polymorphic epithelial mucin [CTM01] |
Human |
IP, therapeutic, IHC |
Anti-PSA [8G8F5] |
Human |
ELISA |
Anti-PSA [scFv B8] |
Human |
SPR, WB |
Anti-PSMA [11d1e5E10] |
Human |
ELISA, IHC |
Anti-PSMA [J591] |
Human |
IP, therapeutic, WB, ELISA, FC, IF, IHC |
Anti-S100 [S1-61] |
Human |
WB, IHC |
Anti-S100B [1C8] |
Human |
therapeutic, ELISA |
Anti-Synaptophysin [SP15] |
Cat, Hamster, Pig, Rat, Human |
WB, ELISA, IHC |
Anti-TAG-72 [Minretumomab (CC49 )] |
Human |
RIA, therapeutic, WB, FC, IHC |
Anti-Tenascin [I-81C6 (Neuradiab)] |
Human |
cross-competition assay, immunoreactivity, radioiodination, ELISA |
Anti-Tn Antigen [237mAb] |
Human, Mouse |
WB, ELISA |
Anti-trastuzumab (anti-idiotype) [scFv40] |
Human |
immunogen, Block |
Anti-trastuzumab (anti-idiotype) [scFv69] |
Human |
immunogen, Block |
Anti-TRP-1, gp75 [TA99] |
Human |
IP, WB, ELISA, FC, IF, IHC-Fr |
Anti-Tumor associated glycoprotein (TAG) 72 [B72.3 (Satumomab)] |
Human |
FC, IHC, Imaging |
Anti-VAP-1 [2D10] |
Human |
IP, WB, ELISA, FC, IHC |
Anti-VAP-1 [3F10] |
Human |
ELISA, IHC |
Anti-VAP-1 [3G6] |
Human |
ELISA, IHC |
Anti-VAP-1 [TK8-14] |
Human |
IP, WB, ELISA, FC, IHC |